Clinical Trials on Nasopharyngeal Cancinoma (NPC) in Hong Kong

Total 634 results

CCTU

Active, not recruiting

NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer

NPC

Hong Kong, Singapore
Chinese University of Hong Kong

Completed

Nasopharyngeal Carcinoma (NPC) Axitinib

Recurrent or Metastatic NPC

Hong Kong
Chinese University of Hong Kong

Completed

New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer

Advanced Nasopharyngeal Carcinoma

Hong Kong
The University of Hong Kong
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt...

Active, not recruiting

Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC

Nasopharyngeal Carcinoma | Metastatic Cancer | Recurrent Carcinoma | Non-keratinizing Carinoma

Hong Kong
Chinese University of Hong Kong

Completed

MK-2206 in Recurrent Nasopharyngeal Carcinoma (MC1079)

Recurrent Nasopharyngeal Carcinoma

Hong Kong
Chinese University of Hong Kong
Hong Kong Nasopharyngeal Cancer Study Group Limited

Completed

A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Nasopharyngeal Cancer

Hong Kong
The University of Hong Kong

Recruiting

Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Hong Kong
The University of Hong Kong

Unknown

Weekly Plasma EBV DNA for Non-metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Hong Kong
Chinese University of Hong Kong

Recruiting

Magnifying NBI for Occult NPC

Nasopharyngeal Carcinoma

Hong Kong
The University of Hong Kong

Unknown

Serial Plasma EBV DNA for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Hong Kong
The University of Hong Kong

Unknown

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

Hong Kong
Pamela Youde Nethersole Eastern Hospital

Completed

NBI to Detect Post-RT Mucosal Residual NPC

Nasopharyngeal Carcinoma

Hong Kong
Sanofi

Completed

Taxotere + Cisplatin in Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

Hong Kong
Sanofi

Completed

Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

Hong Kong
Chinese University of Hong Kong

Completed

IMRT vs 2DRT for NPC Patients

NPC

Hong Kong
Chinese University of Hong Kong

Completed

Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy

Nasopharyngeal Cancer | Epstein-Barr Virus Infections

Hong Kong
Zeng Changhao

Recruiting

Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma

Dysphagia

Hong Kong
Hospital Authority, Hong Kong
The Hong Kong Nasopharyngeal Cancer Study Group

Terminated

Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)

Carcinoma, Squamous Cell | Nasopharyngeal Neoplasms

China
Hospital Authority, Hong Kong
Hong Kong Nasopharyngeal Cancer Study Group Limited

Unknown

Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)

Carcinoma, Squamous Cell | Nasopharyngeal Neoplasms

China
Hospital Authority, Hong Kong
Hong Kong Nasopharyngeal Cancer Study Group Limited

Unknown

Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer

Nasopharyngeal Neoplasms

China
Chinese University of Hong Kong

Active, not recruiting

Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis

Nasopharyngeal Carcinoma

Hong Kong
Hong Kong Nasopharyngeal Cancer Study Group Limited
Sanofi; The University of Hong Kong; Merck Sharp & Dohme LLC; Roche Pharma AG

Completed

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

Nasopharyngeal Carcinoma

China
Hong Kong Nasopharyngeal Cancer Study Group Limited
The Hong Kong Anti-Cancer Society; hong Kong Cancer Fund

Completed

Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Johns Hopkins University
Janssen-Cilag Ltd.

Withdrawn

Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China, Singapore
Chinese University of Hong Kong

Active, not recruiting

NPC - AXEL Study : Axitinib-Avelumab

Recurrent or Metastatic NPC

Hong Kong
The University of Hong Kong

Recruiting

Oral Arsenic Trioxide for NPM1-mutated AML

NPMc+ AML

Hong Kong
Chinese University of Hong Kong
Queen Elizabeth Hospital, Hong Kong; Prince of Wales Hospital, Shatin, Hong...

Unknown

Dysphagia Rehabilitation for Nasopharyngeal Carcinoma Patients Post Radiotherapy

Nasopharyngeal Carcinoma | Radiotherapy

Hong Kong
Chinese University of Hong Kong

Completed

Modified Vaccinia Ankara (MVA) Vaccine Study

Nasopharyngeal Neoplasms | Epstein-Barr Virus Infections

Hong Kong
Humanity & Health Medical Group Limited

Recruiting

Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC

Hepatocellular Carcinoma

Hong Kong
Humanity & Health Medical Group Limited
Beijing 302 Hospital; Kindai University Faculty of Medicine

Terminated

Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint Inhibitors

Hepatocellular Carcinoma

Hong Kong
Hoffmann-La Roche

Completed

A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer

Nasopharyngeal Cancer

Hong Kong, Thailand, Indonesia, Taiwan, Malaysia
The University of Hong Kong
Food and Health Bureau, Hong Kong Government

Active, not recruiting

Hong Kong Breast Cancer Study

Breast Cancer | Ductal Carcinoma In Situ

Hong Kong
The University of Hong Kong

Recruiting

Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning

Oral Squamous Cell Carcinoma

Hong Kong
Chinese University of Hong Kong
Health and Medicine Research Fund

Recruiting

Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular Carcinoma (AP-LAPO)

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong
The Hong Kong Society of Gastroenterology

Completed

Cytokine Change in Hepatocellular Carcinoma Treated by Thermal Ablation

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Study of Pegylated Human Recombinant Arginase for Liver Cancer

Hepatocellular Carcinoma | Neoplasm

Hong Kong
Chinese University of Hong Kong

Recruiting

The Microbiome of Oesophageal Squamous Cell Carcinoma

Esophageal Cancer | Microbial Colonization

Hong Kong
The University of Hong Kong

Recruiting

SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Substudy: Interconnection of Arterial Tumor Feeders Through Tumor Sinusoid in HCC

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Balloon Assisted Transarterial Therapy for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Terminated

Chemoembolization for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong

Completed

Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC (PACOX)

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Treatment for Bile Duct Cancer in the Liver

Cholangio Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Hepatocellular Carcinoma (HCC)_Torisel_

Inoperable HCC

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) (BCT-100-002)

Hepatocellular Carcinoma | Neoplasm

Hong Kong
CCTU

Recruiting

Pembrolizumab in Hepatocellular Carcinoma

HCC

Hong Kong
The University of Hong Kong

Recruiting

TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma

HCC

Hong Kong
Yung NA
Queen Mary Hospital, Hong Kong; Pamela Youde Nethersole Eastern Hospital

Recruiting

Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma: A Pilot Randomized Controlled Trial

Muscle-Invasive Bladder Carcinoma | Muscle Invasive Bladder Urothelial Carcinoma

Hong Kong

Clinical Trials on Nasopharyngeal Cancinoma (NPC) in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations